Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Ylikorkala O et al. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy. 2000 Clin Ther pmid:10868559
Vecchi A et al. Steroid contraceptive agents and immunological reactivity in experimental animals. 1976 Biomedicine pmid:1086685
Ozsener S et al. The effect of continuous combined oral estradiol and norethisterone on the renal and internal carotid artery pulsatility indices in postmenopausal women. 2000 Int J Gynaecol Obstet pmid:10854874
El Bouhmadi A et al. 100 mg acetylsalicylic acid acutely decreases red cell aggregation in women taking oral contraceptives. 2000 Clin. Hemorheol. Microcirc. pmid:10831061
Verhoeven CH et al. Excretion balance and metabolism of the progestagen Org 30659 in healthy postmenopausal women. 2000 J. Steroid Biochem. Mol. Biol. pmid:10822023
Owens D et al. Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate. 2000 Diabet. Med. pmid:10821298
Teede HJ et al. Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis. 2000 Arterioscler. Thromb. Vasc. Biol. pmid:10807761
Bständig B et al. Effectiveness of low dose of gonadotropin releasing hormone agonist on hormonal flare-up. 2000 J. Assist. Reprod. Genet. pmid:10806591
Fraser IS et al. Vaginal epithelial surface appearances in women using vaginal rings for contraception. 2000 Contraception pmid:10802278
Stachenfeld NS et al. Estrogen modifies the temperature effects of progesterone. 2000 J. Appl. Physiol. pmid:10797125
Lethaby AE et al. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding. 2000 Cochrane Database Syst Rev pmid:10796865
Lethaby A et al. Cyclical progestogens for heavy menstrual bleeding. 2000 Cochrane Database Syst Rev pmid:10796587
Cooke I et al. Antifibrinolytics for heavy menstrual bleeding. 2000 Cochrane Database Syst Rev pmid:10796518
Gravholt CH et al. Lp(a) and lipids in adult Turner's syndrome: impact of treatment with 17beta-estradiol and norethisterone. 2000 Atherosclerosis pmid:10781652
Shen Y et al. Regulation of biodegradability and drug release behavior of aliphatic polyesters by blending. 2000 J. Biomed. Mater. Res. pmid:10756311
Cagnacci A et al. Transdermal administration of estradiol and norethisterone: effect on the uterus and uterine arteries. 2000 Mar-Apr Menopause pmid:10746894
Cromie MA et al. Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic) on lipid profiles. Investigators from the Lunelle Study Group. 2000 Contraception pmid:10745070
Alexandersen P et al. Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effects. 2000 BJOG pmid:10740332
Byrjalsen I et al. Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium. 2000 BJOG pmid:10740331
Thorneycroft IH et al. Effect of low-dose oral contraceptives on androgenic markers and acne. 1999 Contraception pmid:10717776